位置:首页 > 蛋白库 > KHDC3_MOUSE
KHDC3_MOUSE
ID   KHDC3_MOUSE             Reviewed;         440 AA.
AC   Q9CWU5; A7YIL2; Q9CRD6;
DT   03-MAY-2011, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   03-AUG-2022, entry version 130.
DE   RecName: Full=KH domain-containing protein 3;
DE   AltName: Full=Protein Filia {ECO:0000303|PubMed:18057100};
GN   Name=Khdc3;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), INTERACTION WITH NLRP5,
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, DEVELOPMENTAL STAGE, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Ovary {ECO:0000269|PubMed:18057100};
RX   PubMed=18057100; DOI=10.1242/dev.011445;
RA   Ohsugi M., Zheng P., Baibakov B., Li L., Dean J.;
RT   "Maternally derived FILIA-MATER complex localizes asymmetrically in
RT   cleavage-stage mouse embryos.";
RL   Development 135:259-269(2008).
RN   [2] {ECO:0000305, ECO:0000312|EMBL:BAD95487.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Yamanaka S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000305, ECO:0000312|EMBL:BAD95487.1}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Ovary {ECO:0000312|EMBL:ABK91524.1};
RA   Sachdev M., Mandal A., Chertihin O., Digilio L., Flickinger C.J.,
RA   Herr J.C.;
RT   "OEEP, an egg and embryo specific protein, predominantly restricted to the
RT   periphery of the oocyte and early embryonic stages.";
RL   Submitted (AUG-2006) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000305, ECO:0000312|EMBL:BAB26895.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   STRAIN=C57BL/6J {ECO:0000312|EMBL:BAB26895.1};
RC   TISSUE=Embryonic stem cell {ECO:0000312|EMBL:BAB26895.1};
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [5] {ECO:0000305, ECO:0000312|EMBL:BAD95487.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6] {ECO:0000305, ECO:0000312|EMBL:AAI37809.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   IDENTIFICATION.
RX   PubMed=17913455; DOI=10.1016/j.ygeno.2007.06.003;
RA   Pierre A., Gautier M., Callebaut I., Bontoux M., Jeanpierre E.,
RA   Pontarotti P., Monget P.;
RT   "Atypical structure and phylogenomic evolution of the new eutherian
RT   oocyte- and embryo-expressed KHDC1/DPPA5/ECAT1/OOEP gene family.";
RL   Genomics 90:583-594(2007).
RN   [8] {ECO:0000305}
RP   FUNCTION, IDENTIFICATION IN THE SCMC COMPLEX, SUBCELLULAR LOCATION, AND
RP   INTERACTION WITH NLRP5.
RX   PubMed=18804437; DOI=10.1016/j.devcel.2008.07.010;
RA   Li L., Baibakov B., Dean J.;
RT   "A subcortical maternal complex essential for preimplantation mouse
RT   embryogenesis.";
RL   Dev. Cell 15:416-425(2008).
RN   [9] {ECO:0000305}
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=19376971; DOI=10.1073/pnas.0900519106;
RA   Zheng P., Dean J.;
RT   "Role of Filia, a maternal effect gene, in maintaining euploidy during
RT   cleavage-stage mouse embryogenesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:7473-7478(2009).
RN   [10]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=25208553; DOI=10.1038/ncomms5887;
RA   Yu X.J., Yi Z., Gao Z., Qin D., Zhai Y., Chen X., Ou-Yang Y., Wang Z.B.,
RA   Zheng P., Zhu M.S., Wang H., Sun Q.Y., Dean J., Li L.;
RT   "The subcortical maternal complex controls symmetric division of mouse
RT   zygotes by regulating F-actin dynamics.";
RL   Nat. Commun. 5:4887-4887(2014).
RN   [11]
RP   FUNCTION, INTERACTION WITH PARP1 AND NUMA1, SUBCELLULAR LOCATION,
RP   INDUCTION, PHOSPHORYLATION AT SER-349, AND MUTAGENESIS OF SER-349.
RX   PubMed=25936915; DOI=10.1016/j.stem.2015.03.017;
RA   Zhao B., Zhang W.D., Duan Y.L., Lu Y.Q., Cun Y.X., Li C.H., Guo K.,
RA   Nie W.H., Li L., Zhang R., Zheng P.;
RT   "Filia Is an ESC-Specific Regulator of DNA Damage Response and Safeguards
RT   Genomic Stability.";
RL   Cell Stem Cell 16:684-698(2015).
RN   [12]
RP   FUNCTION, INTERACTION WITH OOEP; BLM AND TRIM25, SUBCELLULAR LOCATION,
RP   DISRUPTION PHENOTYPE, PHOSPHORYLATION AT SER-151, AND MUTAGENESIS OF
RP   SER-151 AND SER-349.
RX   PubMed=29125140; DOI=10.1038/cr.2017.139;
RA   Zhao B., Zhang W., Cun Y., Li J., Liu Y., Gao J., Zhu H., Zhou H.,
RA   Zhang R., Zheng P.;
RT   "Mouse embryonic stem cells have increased capacity for replication fork
RT   restart driven by the specific Filia-Floped protein complex.";
RL   Cell Res. 28:69-89(2018).
RN   [13]
RP   FUNCTION, AND IDENTIFICATION IN THE SCMC COMPLEX.
RX   PubMed=28992324; DOI=10.1093/jmcb/mjx035;
RA   Gao Z., Zhang X., Yu X., Qin D., Xiao Y., Yu Y., Xiang Y., Nie X., Lu X.,
RA   Liu W., Yi Z., Li L.;
RT   "Zbed3 participates in the subcortical maternal complex and regulates the
RT   distribution of organelles.";
RL   J. Mol. Cell Biol. 10:74-88(2018).
RN   [14]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=31575650; DOI=10.1242/dev.183616;
RA   Qin D., Gao Z., Xiao Y., Zhang X., Ma H., Yu X., Nie X., Fan N., Wang X.,
RA   Ouyang Y., Sun Q.Y., Yi Z., Li L.;
RT   "The subcortical maternal complex protein Nlrp4f is involved in cytoplasmic
RT   lattice formation and organelle distribution.";
RL   Development 146:0-0(2019).
RN   [15]
RP   FUNCTION, SUBCELLULAR LOCATION, DEVELOPMENTAL STAGE, INDUCTION, AND
RP   DISRUPTION PHENOTYPE.
RX   PubMed=33115731; DOI=10.1126/sciadv.aba0682;
RA   Li J., Shang Y., Wang L., Zhao B., Sun C., Li J., Liu S., Li C., Tang M.,
RA   Meng F.L., Zheng P.;
RT   "Genome integrity and neurogenesis of postnatal hippocampal neural
RT   stem/progenitor cells require a unique regulator Filia.";
RL   Sci. Adv. 6:0-0(2020).
RN   [16] {ECO:0000305}
RP   PRELIMINARY X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 1-124.
RX   PubMed=20823540; DOI=10.1107/s1744309110031994;
RA   Wang J., Zhang T.C., Liu X.;
RT   "Preliminary crystallographic analysis of the N-terminal domain of FILIA, a
RT   protein essential for embryogenesis.";
RL   Acta Crystallogr. F 66:1111-1114(2010).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 1-124, FUNCTION, AND DOMAIN.
RX   PubMed=22276159; DOI=10.1371/journal.pone.0030209;
RA   Wang J., Xu M., Zhu K., Li L., Liu X.;
RT   "The N-terminus of FILIA forms an atypical KH domain with a unique
RT   extension involved in interaction with RNA.";
RL   PLoS ONE 7:0-0(2012).
CC   -!- FUNCTION: As part of the OOEP-KHDC3 scaffold, recruits BLM and TRIM25
CC       to DNA replication forks, thereby promoting the ubiquitination of BLM
CC       by TRIM25, enhancing BLM retainment at replication forks and therefore
CC       promoting stalled replication fork restart (PubMed:29125140,
CC       PubMed:33115731). Regulates homologous recombination-mediated DNA
CC       repair via recruitment of RAD51 to sites of DNA double-strand breaks,
CC       and sustainment of PARP1 activity, which in turn modulates downstream
CC       ATM or ATR activation (PubMed:25936915, PubMed:33115731). Activation of
CC       ATM or ATR in response to DNA double-strand breaks may be cell-type
CC       specific (PubMed:25936915, PubMed:33115731). Its role in DNA double-
CC       strand break repair is independent of its role in restarting stalled
CC       replication forks (PubMed:29125140). As a member of the subcortical
CC       maternal complex (SCMC), plays an essential role for zygotes to
CC       progress beyond the first embryonic cell divisions via regulation of
CC       actin dynamics (PubMed:18804437, PubMed:29125140, PubMed:28992324,
CC       PubMed:31575650). Required for maintenance of euploidy during cleavage-
CC       stage embryogenesis (PubMed:19376971). Required for the formation of F-
CC       actin cytoplasmic lattices in oocytes which in turn are responsible for
CC       symmetric division of zygotes via the regulation of mitotic spindle
CC       formation and positioning (PubMed:25208553, PubMed:31575650). Ensures
CC       proper spindle assembly by regulating the localization of AURKA via
CC       RHOA signaling and of PLK1 via a RHOA-independent process
CC       (PubMed:19376971). Required for the localization of MAD2L1 to
CC       kinetochores to enable spindle assembly checkpoint function
CC       (PubMed:19376971). Promotes neural stem cell neurogenesis and neuronal
CC       differentiation in the hippocampus (PubMed:33115731). May regulate
CC       normal development of learning, memory and anxiety (PubMed:33115731).
CC       Capable of binding RNA (PubMed:22276159). {ECO:0000269|PubMed:18804437,
CC       ECO:0000269|PubMed:19376971, ECO:0000269|PubMed:22276159,
CC       ECO:0000269|PubMed:25208553, ECO:0000269|PubMed:25936915,
CC       ECO:0000269|PubMed:28992324, ECO:0000269|PubMed:29125140,
CC       ECO:0000269|PubMed:31575650, ECO:0000269|PubMed:33115731}.
CC   -!- SUBUNIT: Component of the subcortical maternal complex (SCMC), at least
CC       composed of NLRP5, KHDC3, OOEP, and TLE6 (PubMed:18057100,
CC       PubMed:18804437, PubMed:28992324). Within the complex, interacts with
CC       NLRP5, OOEP and TLE6 (PubMed:18057100, PubMed:18804437). The SCMC may
CC       facilitate translocation of its components between the nuclear and
CC       cytoplasmic compartments (By similarity). Forms a scaffold complex with
CC       OOEP/FLOPED, and interacts with BLM and TRIM25 at DNA replication forks
CC       (PubMed:29125140). Interacts with PARP1; the interaction is increased
CC       following the formation of DNA double-strand breaks (PubMed:25936915).
CC       Interacts (via C-terminus) with NUMA1 (PubMed:25936915).
CC       {ECO:0000250|UniProtKB:Q587J8, ECO:0000269|PubMed:18057100,
CC       ECO:0000269|PubMed:18804437, ECO:0000269|PubMed:25936915,
CC       ECO:0000269|PubMed:28992324, ECO:0000269|PubMed:29125140}.
CC   -!- INTERACTION:
CC       Q9CWU5; Q9R1M5: Nlrp5; NbExp=3; IntAct=EBI-2905804, EBI-2905719;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cell cortex
CC       {ECO:0000269|PubMed:18057100, ECO:0000269|PubMed:18804437,
CC       ECO:0000269|PubMed:25936915}. Nucleus {ECO:0000269|PubMed:25936915,
CC       ECO:0000269|PubMed:29125140, ECO:0000269|PubMed:33115731}.
CC       Mitochondrion {ECO:0000269|PubMed:25936915}. Cytoplasm, cytoskeleton,
CC       microtubule organizing center, centrosome
CC       {ECO:0000269|PubMed:25936915}. Chromosome
CC       {ECO:0000250|UniProtKB:Q587J8}. Note=Localized to centrosomes during
CC       interphase and mitosis (PubMed:25936915). Localizes to sites of DNA
CC       double-strand break repair (By similarity). Localization to the
CC       mitochondrion during apoptosis following phosphorylation of Ser-349
CC       (PubMed:25936915). Expressed in the subcortex of oocytes
CC       (PubMed:25208553). Located throughout the cell cortex of ovulated eggs
CC       in a complex with NLRP5 (PubMed:18057100). After fertilization,
CC       restricted to the apical cortex and excluded from regions of cell-cell
CC       contact (PubMed:18057100). {ECO:0000250|UniProtKB:Q587J8,
CC       ECO:0000269|PubMed:18057100, ECO:0000269|PubMed:25208553,
CC       ECO:0000269|PubMed:25936915}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1 {ECO:0000269|PubMed:18057100}; Synonyms=Filia 1.6
CC       {ECO:0000269|PubMed:18057100};
CC         IsoId=Q9CWU5-1; Sequence=Displayed;
CC       Name=2 {ECO:0000269|PubMed:18057100}; Synonyms=Filia 1.2
CC       {ECO:0000269|PubMed:18057100};
CC         IsoId=Q9CWU5-2; Sequence=VSP_040951, VSP_040952;
CC       Name=3 {ECO:0000269|Ref.3};
CC         IsoId=Q9CWU5-3; Sequence=VSP_040950;
CC   -!- TISSUE SPECIFICITY: Detected in ovary, but not in testis or somatic
CC       tissues. In the ovary, expressed in growing oocytes.
CC       {ECO:0000269|PubMed:18057100}.
CC   -!- DEVELOPMENTAL STAGE: Expressed in the brain at low levels during fetal
CC       development, from 13.5 dpc to 18.5 dpc, however significantly increased
CC       after birth from P1 to P60 (PubMed:33115731). Highly expressed in
CC       neural stem progenitor cells in the hippocampus after birth
CC       (PubMed:33115731). {ECO:0000269|PubMed:33115731}.
CC   -!- DEVELOPMENTAL STAGE: [Isoform 1]: Expressed in growing oocytes but
CC       diminishes in fully grown oocytes (PubMed:18057100). Detected at very
CC       low levels in morula and early blastocyst (PubMed:18057100).
CC       {ECO:0000269|PubMed:18057100}.
CC   -!- DEVELOPMENTAL STAGE: [Isoform 2]: Expressed in growing oocytes,
CC       ovulated eggs and preimplantation embryos up to the morula stage and
CC       decreases markedly at the blastocyst stage (at protein level).
CC       {ECO:0000269|PubMed:18057100}.
CC   -!- INDUCTION: Induced by ultraviolet light, etoposide, doxorubicin,
CC       camptothecin and hydroxyl urea in embryonic stem cells
CC       (PubMed:25936915). Induced by etoposide and hydroxy urea in neural stem
CC       cells (PubMed:33115731). {ECO:0000269|PubMed:25936915,
CC       ECO:0000269|PubMed:33115731}.
CC   -!- DOMAIN: Contains 1 atypical KH domain, which is still capable of
CC       binding RNA. {ECO:0000269|PubMed:22276159}.
CC   -!- PTM: Phosphorylation at Ser-151 is required to promote stalled fork
CC       restart. {ECO:0000269|PubMed:29125140}.
CC   -!- DISRUPTION PHENOTYPE: Reduced fecundity and impaired preimplantation
CC       embryo development with a high incidence of aneuploidy due to abnormal
CC       spindle assembly, chromosomal misalignment and spindle assembly
CC       checkpoint inactivation (PubMed:19376971). Loss of cytoplasmic lattices
CC       and aberrant organelle distribution in oocytes (PubMed:31575650).
CC       Increase in abnormal embryonic structure and loss of the embryo
CC       following compromised post-implantation embryo development
CC       (PubMed:29125140). Knockout mice show normal brain structure and weight
CC       (PubMed:33115731). Increased DNA double-strand breaks in hippocampus
CC       neural stem cells at P1 to 1 year of age (PubMed:33115731). Reduced
CC       hippocampal neural stem cell proliferation from P7 to P60
CC       (PubMed:33115731). Reduced differentiation of neurons and dendritic
CC       spines formation in the dentate gyrus from P13 to P66
CC       (PubMed:33115731). Impaired hippocampus-dependent spatial learning,
CC       memory and anxiety from 2 months to 1 year of age (PubMed:33115731).
CC       {ECO:0000269|PubMed:19376971, ECO:0000269|PubMed:29125140,
CC       ECO:0000269|PubMed:31575650, ECO:0000269|PubMed:33115731}.
CC   -!- SIMILARITY: Belongs to the KHDC1 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB211060; BAD95487.1; -; mRNA.
DR   EMBL; DQ917421; ABK91524.1; -; mRNA.
DR   EMBL; DQ917422; ABK91525.1; -; mRNA.
DR   EMBL; AK010377; BAB26895.1; -; mRNA.
DR   EMBL; AK021223; BAB32334.1; -; mRNA.
DR   EMBL; CH466522; EDL26289.1; -; Genomic_DNA.
DR   EMBL; BC137808; AAI37809.1; -; mRNA.
DR   EMBL; BC137809; AAI37810.1; -; mRNA.
DR   CCDS; CCDS23336.1; -. [Q9CWU5-1]
DR   CCDS; CCDS81036.1; -. [Q9CWU5-2]
DR   RefSeq; NP_001298035.1; NM_001311106.1. [Q9CWU5-2]
DR   RefSeq; NP_080166.1; NM_025890.3. [Q9CWU5-1]
DR   PDB; 3V69; X-ray; 2.20 A; A/B=1-124.
DR   PDBsum; 3V69; -.
DR   AlphaFoldDB; Q9CWU5; -.
DR   SMR; Q9CWU5; -.
DR   BioGRID; 211859; 1.
DR   CORUM; Q9CWU5; -.
DR   IntAct; Q9CWU5; 3.
DR   STRING; 10090.ENSMUSP00000034737; -.
DR   iPTMnet; Q9CWU5; -.
DR   PhosphoSitePlus; Q9CWU5; -.
DR   REPRODUCTION-2DPAGE; Q9CWU5; -.
DR   CPTAC; non-CPTAC-3979; -.
DR   PaxDb; Q9CWU5; -.
DR   PRIDE; Q9CWU5; -.
DR   ProteomicsDB; 263434; -. [Q9CWU5-1]
DR   ProteomicsDB; 263435; -. [Q9CWU5-2]
DR   ProteomicsDB; 263436; -. [Q9CWU5-3]
DR   DNASU; 66991; -.
DR   Ensembl; ENSMUST00000034737; ENSMUSP00000034737; ENSMUSG00000092622. [Q9CWU5-1]
DR   Ensembl; ENSMUST00000167514; ENSMUSP00000132527; ENSMUSG00000092622. [Q9CWU5-3]
DR   Ensembl; ENSMUST00000173734; ENSMUSP00000133915; ENSMUSG00000092622. [Q9CWU5-2]
DR   GeneID; 66991; -.
DR   KEGG; mmu:66991; -.
DR   UCSC; uc009qqy.2; mouse. [Q9CWU5-1]
DR   UCSC; uc009qqz.2; mouse. [Q9CWU5-2]
DR   CTD; 66991; -.
DR   MGI; MGI:1914241; Khdc3.
DR   VEuPathDB; HostDB:ENSMUSG00000092622; -.
DR   eggNOG; ENOG502QQIF; Eukaryota.
DR   GeneTree; ENSGT00940000162601; -.
DR   HOGENOM; CLU_050702_0_0_1; -.
DR   InParanoid; Q9CWU5; -.
DR   OMA; AVWRADY; -.
DR   OrthoDB; 913590at2759; -.
DR   PhylomeDB; Q9CWU5; -.
DR   TreeFam; TF338690; -.
DR   BioGRID-ORCS; 66991; 1 hit in 71 CRISPR screens.
DR   PRO; PR:Q9CWU5; -.
DR   Proteomes; UP000000589; Chromosome 9.
DR   RNAct; Q9CWU5; protein.
DR   Bgee; ENSMUSG00000092622; Expressed in morula and 35 other tissues.
DR   ExpressionAtlas; Q9CWU5; baseline and differential.
DR   Genevisible; Q9CWU5; MM.
DR   GO; GO:0045179; C:apical cortex; IBA:GO_Central.
DR   GO; GO:0005938; C:cell cortex; IDA:UniProtKB.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005694; C:chromosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005737; C:cytoplasm; ISO:MGI.
DR   GO; GO:0005739; C:mitochondrion; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IDA:MGI.
DR   GO; GO:0106333; C:subcortical maternal complex; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0007015; P:actin filament organization; IMP:UniProtKB.
DR   GO; GO:0051656; P:establishment of organelle localization; IMP:UniProtKB.
DR   GO; GO:0090307; P:mitotic spindle assembly; IMP:MGI.
DR   GO; GO:0007094; P:mitotic spindle assembly checkpoint signaling; IMP:MGI.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:UniProtKB.
DR   GO; GO:1900006; P:positive regulation of dendrite development; IMP:UniProtKB.
DR   GO; GO:2000781; P:positive regulation of double-strand break repair; IMP:UniProtKB.
DR   GO; GO:1905168; P:positive regulation of double-strand break repair via homologous recombination; IMP:UniProtKB.
DR   GO; GO:0040019; P:positive regulation of embryonic development; IMP:UniProtKB.
DR   GO; GO:0050769; P:positive regulation of neurogenesis; IMP:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IMP:MGI.
DR   GO; GO:0032880; P:regulation of protein localization; IMP:UniProtKB.
DR   GO; GO:0031297; P:replication fork processing; IMP:UniProtKB.
DR   CDD; cd12795; FILIA_N_like; 1.
DR   Gene3D; 3.30.1370.10; -; 1.
DR   InterPro; IPR036612; KH_dom_type_1_sf.
DR   InterPro; IPR031952; MOEP19_KH-like.
DR   Pfam; PF16005; MOEP19; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell cycle; Chromosome; Cytoplasm;
KW   Cytoskeleton; Developmental protein; Mitochondrion; Nucleus;
KW   Phosphoprotein; Reference proteome; RNA-binding.
FT   CHAIN           1..440
FT                   /note="KH domain-containing protein 3"
FT                   /id="PRO_0000407378"
FT   DOMAIN          40..118
FT                   /note="KH; atypical"
FT   REGION          1..39
FT                   /note="Involved in RNA binding"
FT                   /evidence="ECO:0000269|PubMed:22276159"
FT   REGION          132..201
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          341..440
FT                   /note="Required for interaction with NUMA1 and regulation
FT                   of apoptosis in response to DNA damage"
FT                   /evidence="ECO:0000269|PubMed:25936915"
FT   SITE            151
FT                   /note="Not required for interaction with OOEP"
FT                   /evidence="ECO:0000269|PubMed:29125140"
FT   MOD_RES         151
FT                   /note="Phosphoserine; by ATR"
FT                   /evidence="ECO:0000269|PubMed:29125140"
FT   MOD_RES         274
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q587J8"
FT   MOD_RES         286
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q587J8"
FT   MOD_RES         349
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:25936915"
FT   VAR_SEQ         148..171
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|Ref.3"
FT                   /id="VSP_040950"
FT   VAR_SEQ         341..346
FT                   /note="VREAAT -> ESGRTE (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:18057100"
FT                   /id="VSP_040951"
FT   VAR_SEQ         347..440
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:18057100"
FT                   /id="VSP_040952"
FT   MUTAGEN         151
FT                   /note="S->A: Reduces restart of stalled replication forks
FT                   and cells show an increase in DNA double strand breaks.
FT                   Decreases phosphorylation of ATR at 'S-428'. Reduces TRIM25
FT                   ubiquitination of BLM and subsequent localization to DNA
FT                   replication forks. Reduces phosphorylation and activation
FT                   of ATR. No effect on Filia distribution at replication
FT                   forks or nascent DNA degradation following DNA damage. Not
FT                   effect on interaction with OOEP."
FT                   /evidence="ECO:0000269|PubMed:29125140"
FT   MUTAGEN         151
FT                   /note="S->D: No effect on localization at replication
FT                   forks, nascent DNA degradation following DNA damage,
FT                   restart of stalled replication forks or levels of DNA
FT                   damage."
FT                   /evidence="ECO:0000269|PubMed:29125140"
FT   MUTAGEN         349
FT                   /note="S->A: Abolishes localization to the nucleus and
FT                   enhances localization to the mitochondrion. Reduces stalled
FT                   replication fork restart. Abolishes ATR-mediated
FT                   phosphorylation of S-151. No effect on phosphorylation and
FT                   activation of ATR. No effect on localization to centrosomes
FT                   or centrosome integrity."
FT                   /evidence="ECO:0000269|PubMed:25936915,
FT                   ECO:0000269|PubMed:29125140"
FT   MUTAGEN         349
FT                   /note="S->D: Abolishes DNA double-strand break repair and
FT                   subsequent regulation of apoptosis. Abolishes localization
FT                   to the mitochondrion. No effect on localization to
FT                   centrosomes or centrosome integrity."
FT                   /evidence="ECO:0000269|PubMed:25936915"
FT   STRAND          13..17
FT                   /evidence="ECO:0007829|PDB:3V69"
FT   STRAND          20..23
FT                   /evidence="ECO:0007829|PDB:3V69"
FT   HELIX           35..38
FT                   /evidence="ECO:0007829|PDB:3V69"
FT   STRAND          42..46
FT                   /evidence="ECO:0007829|PDB:3V69"
FT   HELIX           48..50
FT                   /evidence="ECO:0007829|PDB:3V69"
FT   HELIX           51..55
FT                   /evidence="ECO:0007829|PDB:3V69"
FT   HELIX           57..59
FT                   /evidence="ECO:0007829|PDB:3V69"
FT   HELIX           62..69
FT                   /evidence="ECO:0007829|PDB:3V69"
FT   STRAND          71..76
FT                   /evidence="ECO:0007829|PDB:3V69"
FT   STRAND          84..90
FT                   /evidence="ECO:0007829|PDB:3V69"
FT   HELIX           92..116
FT                   /evidence="ECO:0007829|PDB:3V69"
SQ   SEQUENCE   440 AA;  47995 MW;  19C1B93DACC42851 CRC64;
     MASLKRFQTL VPLDHKQGTL FEIIGEPKLP KWFHVECLED PKRLYVEPRL LEIMFGKDGE
     HIPHLESMLH TLIHVNVWGP ERRAEIWIFG PPPFRRDVDR MLTDLAHYCR MKLMEIEALE
     AGVERRRMAA HKAATQPAPV KVREAAPRPA SVKVPETATQ PAPVKVREAA PQPAPVQEVR
     EAAPQQASVQ EEVREAATEQ APVQEVREAA TEQAPVQEVS EAATEQAPVQ EVNEAATEQA
     SVQAVREAAT RPAPGKVRKA ATQPAPVQVC QEATQLAPVK VREAATQPAS GKVREAATQL
     APVKVRKAAT QLAPVKVHEA ATQPAPGKVS DAATQSASVQ VREAATQLSP VEATDTSQLA
     QVKADEAFAQ HTSGEAHQVA NGQSPIEVCE TATGQHSLDV SRALSQKCPE VFEWETQSCL
     DGSYVIVQPP RDAWESFIIL
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024